AstraZeneca
Thermo Fisher Scientific, AstraZeneca to Develop Solid Tissue and Blood-Based CDx Test
The firms will develop the NGS-based CDx for non-small cell lung cancer drug Tagrisso using the Oncomine Dx Express Test on the Genexus Dx System.
AstraZeneca to Evaluate C2i Genomics' Cancer Detection, Monitoring Platform
AstraZeneca will assess the startup's test on patient-derived samples, following a previous collaboration that used artificially generated samples.
Tempus, AstraZeneca Collaborate on Response Biomarker Discovery for Small Cell Lung Cancer
This clinical study, called Sculptor, is the first research to emerge from a strategic collaboration between the companies on oncology therapeutics.
Guardant Health, AstraZeneca Partner on Liquid Biopsy CDx for Breast Cancer Drug
The companies forged a multi-year partnership in 2018 to develop blood-based companion diagnostic tests for drugs in AstraZeneca's oncology portfolio.
Exome Sequencing Study Identifies Potential Treatment Target for Diabetes
Individuals with protein-truncating MAP3K15 variants are less likely to develop diabetes, suggesting it could also be a possible target for managing the disease.